Eligibility  /  NAD+

Who can, and can't, start NAD+.

NAD+ has a short contraindication list and a wide eligibility window. The conditions that are on it matter, though, especially active cancer.

You are likely a fit if

NAD+ subq is best suited to healthy adults wanting cellular and recovery support.

×Hard contraindications, we will not prescribe

!Conditions that require extra care

Pre-start labs we require

A general health baseline; no NAD-specific marker is clinically validated yet.

LabWhy
CMPLiver and kidney baseline.
CBCGeneral health screen.
HbA1c, fasting glucoseMetabolic baseline.
Lipid panelCardiometabolic baseline.
TSHThyroid baseline.

If you have labs from the past 6 months, you can upload them, no need to redraw for NAD+ alone.

What to disclose at intake

Lower-risk profile, but not zero.

Take the Find My Protocol intake. Most healthy adults qualify, but cancer history is the absolute filter.

Find my protocol → NAD+ details
Weight-loss medication disclaimer

OPTML offers compounded semaglutide and tirzepatide, prescribed and overseen by U.S.-licensed physicians. Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. OPTML is not associated with, endorsed by, or affiliated with the manufacturers of FDA-approved branded weight-loss medications, and does not sell or supply those branded products. Anyone interested in an FDA-approved branded medication should consult a licensed healthcare provider or pharmacist. Individual results vary; no specific result is promised, and weight management requires ongoing medical guidance.

The complete GLP-1 guide

The whole picture in one sitting: who it suits, what the labs decide, what the first year actually looks like. Every clinical claim is cited.

Free guide

Unlock the free
guide to keeping muscle

How to protect lean mass while losing weight on a GLP-1.

Double-check your email. A typo means we cannot reach you or resend your guide.

We will send occasional emails you can unsubscribe from at any time. See our Privacy Policy.